Literature DB >> 18663030

Surveillance of community-based reservoirs reveals the presence of CTX-M, imported AmpC, and OXA-30 beta-lactamases in urine isolates of Klebsiella pneumoniae and Escherichia coli in a U.S. community.

Nancy D Hanson1, Ellen Smith Moland, S G Hong, Katie Propst, Deborah J Novak, Stephen J Cavalieri.   

Abstract

beta-Lactamases produced by urine isolates from patients in long-term care facilities (LTCFs), outpatient, clinics, and one hospital in a U.S. community were characterized. A total of 1.3% of all Escherichia coli and Klebsiella pneumoniae isolates collected from patients in 30 LTCFs and various outpatient clinics produced extended-spectrum beta-lactamases (ESBLs) and/or imported AmpC beta-lactamases.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18663030      PMCID： PMC2565870          DOI： 10.1128/AAC.00877-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  23 in total

Review 1.  Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community.

Authors:  Johann D D Pitout; Patrice Nordmann; Kevin B Laupland; Laurent Poirel
Journal:  J Antimicrob Chemother       Date:  2005-05-25       Impact factor: 5.790

2.  AmpC disk test for detection of plasmid-mediated AmpC beta-lactamases in Enterobacteriaceae lacking chromosomal AmpC beta-lactamases.

Authors:  Jennifer A Black; Ellen Smith Moland; Kenneth S Thomson
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

3.  Spread of Escherichia coli strains with high-level cefotaxime and ceftazidime resistance between the community, long-term care facilities, and hospital institutions.

Authors:  Jesús Oteo; Carmen Navarro; Emilia Cercenado; Alberto Delgado-Iribarren; Isabel Wilhelmi; Beatriz Orden; Carmen García; Silvia Miguelañez; María Pérez-Vázquez; Silvia García-Cobos; Belén Aracil; Verónica Bautista; José Campos
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

4.  SHV-7, a novel cefotaxime-hydrolyzing beta-lactamase, identified in Escherichia coli isolates from hospitalized nursing home patients.

Authors:  P A Bradford; C Urban; A Jaiswal; N Mariano; B A Rasmussen; S J Projan; J J Rahal; K Bush
Journal:  Antimicrob Agents Chemother       Date:  1995-04       Impact factor: 5.191

5.  Prevalence of newer beta-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002.

Authors:  Ellen S Moland; Nancy D Hanson; Jennifer A Black; Ashfaque Hossain; Wonkeun Song; Kenneth S Thomson
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

6.  Extended-spectrum beta-lactamases in Escherichia coli isolated from dogs and cats in Rome, Italy, from 2001 to 2003.

Authors:  Alessandra Carattoli; Sarah Lovari; Alessia Franco; Gessica Cordaro; Paola Di Matteo; Antonio Battisti
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

Review 7.  Extended-spectrum beta-lactamases: a clinical update.

Authors:  David L Paterson; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

8.  Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes.

Authors:  J Wiener; J P Quinn; P A Bradford; R V Goering; C Nathan; K Bush; R A Weinstein
Journal:  JAMA       Date:  1999-02-10       Impact factor: 56.272

9.  Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.

Authors:  Esther Calbo; Verónica Romaní; Mariona Xercavins; Lucía Gómez; Carolina Garcia Vidal; Salvador Quintana; Jordi Vila; Javier Garau
Journal:  J Antimicrob Chemother       Date:  2006-02-21       Impact factor: 5.790

10.  Population-based laboratory surveillance for AmpC beta-lactamase-producing Escherichia coli, Calgary.

Authors:  Johann D D Pitout; Daniel B Gregson; Deirdre L Church; Kevin B Laupland
Journal:  Emerg Infect Dis       Date:  2007-03       Impact factor: 6.883
View more
  16 in total

1.  Identification of extended-spectrum-β-lactamase-positive Klebsiella pneumoniae urinary tract isolates harboring KPC and CTX-M β-lactamases in nonhospitalized patients.

Authors:  Joanna Kopacz; Noriel Mariano; Rita Colon-Urban; Paul Sychangco; Wehbeh Wehbeh; Sorana Segal-Maurer; Carl Urban
Journal:  Antimicrob Agents Chemother       Date:  2013-07-22       Impact factor: 5.191

2.  "Silent" dissemination of Klebsiella pneumoniae isolates bearing K. pneumoniae carbapenemase in a long-term care facility for children and young adults in Northeast Ohio.

Authors:  Roberto A Viau; Andrea M Hujer; Steven H Marshall; Federico Perez; Kristine M Hujer; David F Briceño; Michael Dul; Michael R Jacobs; Richard Grossberg; Philip Toltzis; Robert A Bonomo
Journal:  Clin Infect Dis       Date:  2012-05       Impact factor: 9.079

3.  Clinical features and molecular epidemiology of CMY-type beta-lactamase-producing Escherichia coli.

Authors:  Hanna E Sidjabat; David L Paterson; Zubair A Qureshi; Jennifer M Adams-Haduch; Alexandra O'Keefe; Alvaro Pascual; Jesús Rodríguez-Baño; Yohei Doi
Journal:  Clin Infect Dis       Date:  2009-03-15       Impact factor: 9.079

4.  Enhancing resistance to cephalosporins in class C beta-lactamases: impact of Gly214Glu in CMY-2.

Authors:  Andrea Endimiani; Yohei Doi; Christopher R Bethel; Magdalena Taracila; Jennifer M Adams-Haduch; Alexandra O'Keefe; Andrea M Hujer; David L Paterson; Marion J Skalweit; Malcolm G P Page; Sarah M Drawz; Robert A Bonomo
Journal:  Biochemistry       Date:  2010-02-09       Impact factor: 3.162

Review 5.  AmpC beta-lactamases.

Authors:  George A Jacoby
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

6.  Antibiotic trapping by plasmid-encoded CMY-2 β-lactamase combined with reduced outer membrane permeability as a mechanism of carbapenem resistance in Escherichia coli.

Authors:  Wil H F Goessens; Akke K van der Bij; Ria van Boxtel; Johann D D Pitout; Peter van Ulsen; Damian C Melles; Jan Tommassen
Journal:  Antimicrob Agents Chemother       Date:  2013-06-03       Impact factor: 5.191

Review 7.  Diversity, epidemiology, and genetics of class D beta-lactamases.

Authors:  Laurent Poirel; Thierry Naas; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2009-08-31       Impact factor: 5.191

8.  Proportion of extended-spectrum ß-lactamase-producing Enterobacteriaceae in community setting in Ngaoundere, Cameroon.

Authors:  Carine Magoué Lonchel; Cécile Meex; Joseph Gangoué-Piéboji; Raphaël Boreux; Marie-Claire Okomo Assoumou; Pierrette Melin; Patrick De Mol
Journal:  BMC Infect Dis       Date:  2012-03-09       Impact factor: 3.090

9.  Extraintestinal Pathogenic Escherichia coli: A Combination of Virulence with Antibiotic Resistance.

Authors:  Johann D D Pitout
Journal:  Front Microbiol       Date:  2012-01-19       Impact factor: 5.640

10.  Analysis of β-lactamase phenotypes and carriage of selected β-lactamase genes among Escherichia coli strains obtained from Kenyan patients during an 18-year period.

Authors:  John Kiiru; Samuel Kariuki; Bruno M Goddeeris; Patrick Butaye
Journal:  BMC Microbiol       Date:  2012-07-28       Impact factor: 3.605
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.